Prognostic Factors for Wilms Tumor Recurrence: A Review of the Literature

Alissa Groenendijk, Filippo Spreafico, Ronald R de Krijger, Jarno Drost, Jesper Brok, Daniela Perotti, Harm van Tinteren, Rajkumar Venkatramani, Jan Godziński, Christian Rübe, James I Geller, Norbert Graf, Marry M van den Heuvel-Eibrink, Annelies M C Mavinkurve-Groothuis

Onderzoeksoutput: Bijdrage aan tijdschriftArtikelpeer review

19 Citaten (Scopus)


In high-income countries, the overall survival of children with Wilms tumors (WT) is ~90%. However, overall, 15% of patients experience tumor recurrence. The adverse prognostic factors currently used for risk stratification (advanced stage, high risk histology, and combined loss of heterozygosity at 1p and 16q in chemotherapy-naïve WTs) are present in only one third of these cases, and the significance of these factors is prone to change with advancing knowledge and improved treatment regimens. Therefore, we present a comprehensive, updated overview of the published prognostic variables for WT recurrence, ranging from patient-, tumor- and treatment-related characteristics to geographic and socioeconomic factors. Improved first-line treatment regimens based on clinicopathological characteristics and advancing knowledge on copy number variations unveil the importance of further investigating the significance of biological markers for WT recurrence in international collaborations.

Originele taal-2Engels
Nummer van het tijdschrift13
StatusGepubliceerd - 23 jun. 2021


Duik in de onderzoeksthema's van 'Prognostic Factors for Wilms Tumor Recurrence: A Review of the Literature'. Samen vormen ze een unieke vingerafdruk.

Citeer dit